Case Report
Seronegative Myelitis with Overlapping NMOSD, MOGAD, And Multiple Sclerosis Features: A Case Report
A.T. Still University, School of Osteopathic Medicine in Arizona, Mesa, United States America.
*Corresponding Author: Leonard B. Goldstein, A.T. Still University, School of Osteopathic Medicine in Arizona, Mesa, United States America.
Citation: Mateen Z, Yim R, Goldstein LB. (2026). Seronegative Myelitis with Overlapping NMOSD, MOGAD, And Multiple Sclerosis Features: A Case Report, International Clinical and Medical Case Reports, BioRes Scientia Publishers. 5(2):1-4. DOI: 10.59657/2837-5998.brs.26.065
Copyright: © 2026 Leonard B. Goldstein, this is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Received: June 01, 2026 | Accepted: June 29, 2026 | Published: July 07, 2026
Abstract
A 43-year-old man with recurrent longitudinally extensive transverse myelitis (LETM) who presented with progressive lower-extremity weakness, urinary incontinence, and falls following an initial steroid-responsive episode. Repeat magnetic resonance imaging demonstrated new enhancing cervical cord lesions and multifocal cerebral lesions despite negative aquaporin-4 and myelin oligodendrocyte glycoprotein antibody testing. Treatment with high-dose intravenous corticosteroids and plasma exchange resulted in significant neurologic improvement, followed by inpatient rehabilitation. This case highlights the diagnostic challenges of recurrent LETM and underscores the importance of timely immunotherapy escalation and early rehabilitation in promoting functional recovery despite diagnostic uncertainty.
Keywords: longitudinally extensive transverse myelitis; neuromyelitis optica spectrum disorder; myelin oligodendrocyte glycoprotein antibody disease; plasma exchange; demyelinating disease
Introduction
Inflammatory myelopathies require early etiologic stratification because diagnosis influences acute treatment decisions, relapse prevention strategies, prognosis, and rehabilitation planning [1-3]. Longitudinally extensive transverse myelitis (LETM), typically defined as a spinal cord lesion extending three or more vertebral segments, is most commonly associated with NMOSD and is also reported in MOGAD, ADEM, sarcoidosis, and infectious myelitis, while being less typical of conventional multiple sclerosis [1-5]. Interval clinical or radiographic progression following an initial episode should prompt reassessment of the underlying disease process [1-5].
We report a case of recurrent LETM with new enhancing cervical spinal cord lesions and evolving multifocal cerebral lesions treated with high-dose corticosteroids, plasma exchange, and subsequent inpatient rehabilitation, highlighting functional recovery despite persistent diagnostic uncertainty.
Case Presentation
Clinical History
A 43-year-old man with obstructive sleep apnea and a prior diagnosis of transverse myelitis (November 2025) presented with two weeks of progressive bilateral lower-extremity weakness and urinary incontinence with intermittent cramping. He reported mechanical falls due to his legs “giving out,” difficulty rising from a squat, and concern about driving due to delayed braking.
During the initial episode, he presented with bilateral leg weakness, erectile dysfunction, and decreased rectal tone. Thoracic spine MRI demonstrated a longitudinally extensive lesion spanning T2-T7, and brain MRI demonstrated a left temporal T2/FLAIR hyperintensity. Lumbar puncture reportedly showed absence of oligoclonal bands. Serum MOG-IgG and AQP4-IgG testing was documented as negative. He partially improved following a five-day course of intravenous methylprednisolone and was discharged on an oral prednisone taper.
Approximately two weeks after completing the taper, he developed recurrent and progressive neurologic deficits prompting re-presentation.
Examination
Neurologic examinations documented diffuse hyperreflexia, bilateral Hoffmann signs, fluctuating lower-extremity weakness, and a sensory level initially around T5 with subsequent rostral fluctuation. Upper-extremity strength was initially preserved, with later reports of right-hand clumsiness and mild grip weakness. Cranial nerve testing was unremarkable.
Diagnostic Studies
MRI performed January 13, 2026 demonstrated new enhancing cervical spinal cord lesions at C4 and C7 and new multifocal supratentorial T2/FLAIR lesions compared with prior imaging. The radiologic differential included NMOSD, MS, ADEM, sarcoidosis, and other autoimmune demyelinating disorders [1-5,8].
Hospital Course and Treatment
Given severe neurologic deficits with interval radiographic progression, the patient received intravenous methylprednisolone (1 g daily for five days). Plasma exchange was initiated with five sessions planned every other day. During hospitalization, neurologic deficits fluctuated, with a documented near-complete loss of lower-extremity movement and a high sensory level. Following completion of corticosteroids and plasma exchange, he demonstrated progressive improvement in lower-extremity strength and bowel and bladder control.
He was transitioned to oral prednisone with a taper plan and discharged to acute inpatient rehabilitation while beginning to stand with approximately 3/5-4/5 lower-extremity strength.
Discussion
Diagnostic Considerations in Recurrent LETM
Recurrent LETM with new cervical cord enhancement and evolving multifocal brain lesions supported an inflammatory demyelinating disorder extending beyond an isolated spinal relapse. LETM is a characteristic imaging feature of NMOSD and is also well described in MOGAD, while being less typical of conventional MS [1-5,8].
MOGAD was considered given LETM, multifocal CNS involvement, and substantial functional improvement following immunotherapy, although repeat negative serum MOG-IgG testing reduced diagnostic confidence [3,9]. NMOSD was also considered, as recurrent severe myelitis with longitudinal involvement is characteristic of the disorder; the absence of optic neuritis and negative AQP4-IgG testing lowered probability without excluding AQP4-IgG-negative NMOSD [1,2]. MS was considered less typical given early LETM, severity of deficits, and absence of cerebrospinal fluid oligoclonal bands, though aggressive MS variants remained part of the differential [6,7,10]. ADEM was considered less likely based on the adult presentation, lack of encephalopathy, and recurrent course [5,11].
Alternative Diagnoses
Cauda equina syndrome was considered but was inconsistent with upper motor neuron signs and intramedullary spinal cord lesions rather than lumbosacral nerve root compression [16,17,21,22]. Guillain-Barré syndrome was also considered but was inconsistent with preserved reflexes, a defined sensory level, and central nervous system imaging abnormalities [18-20].
Rationale for Escalation and Rehabilitation Relevance
High-dose intravenous corticosteroids are commonly used as first-line therapy for severe acute demyelinating attacks [1-3]. In cases of significant or progressive neurologic deficits, plasma exchange is supported as rescue therapy by neurologic and therapeutic guidelines [12-14].
Severe inflammatory myelitis is associated with abrupt functional decline, secondary complications, and prolonged disability risk [15]. Early physiatric involvement and coordinated inpatient rehabilitation are associated with improved functional outcomes, prevention of complications, and safe discharge planning in patients with severe spinal cord and demyelinating disorders [15]. This case demonstrates that meaningful functional recovery can occur despite diagnostic uncertainty when rehabilitation planning is integrated early in the disease course.
Conclusion
Recurrent LETM with radiographic progression should prompt reassessment for inflammatory demyelinating disorders even when antibody testing is negative. In severe presentations, escalation from corticosteroids to plasma exchange may be appropriate. Diagnostic uncertainty does not preclude meaningful functional recovery, and early integration of physiatric care and inpatient rehabilitation can support neurologic and functional improvement.
Highlights
- Recurrent longitudinally extensive myelitis with new enhancing cervical cord lesions prompted reassessment beyond an isolated spinal relapse.
- Negative MOG-IgG and AQP4-IgG testing limited diagnostic certainty despite clinical and radiographic features overlapping with NMOSD and MOGAD.
- Escalation from high-dose corticosteroids to plasma exchange was consistent with rescue therapy used for severe inflammatory demyelinating attacks.
- Functional recovery progressed from near-paralysis to supported standing with partial lower-extremity strength and improving bowel and bladder control, supporting early physiatric involvement and inpatient rehabilitation placement.
Statement of Informed Consent
Informed consent was obtained from the patient that was presented in the case report.
References
- Wingerchuk, D. M., Banwell, B., Bennett, J. L., Cabre, P., Carroll, W., et al. (2015). International Consensus Diagnostic Criteria for Neuromyelitis Optica Spectrum Disorders. Neurology, 85(2):177-189.
Publisher | Google Scholor - Jarius, S., Paul, F., Weinshenker, B. G., Levy, M., Kim, H. J., et al. (2020). Neuromyelitis Optica. Nature Reviews Disease Primers, 6(1):85.
Publisher | Google Scholor - Banwell, B., Bennett, J. L., Marignier, R., Kim, H. J., Brilot, F., et al. (2023). Diagnosis of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: International MOGAD Panel Proposed Criteria. The Lancet Neurology, 22(3):268-282.
Publisher | Google Scholor - Flanagan, E. P. (2019). Neuromyelitis Optica Spectrum Disorder and Other Non-Multiple Sclerosis Central Nervous System Inflammatory Diseases. CONTINUUM: Lifelong Learning in Neurology, 25(3):815-844.
Publisher | Google Scholor - Pohl, D., Alper, G., Van Haren, K., Kornberg, A. J., Lucchinetti, C. F., et al. (2016). Acute Disseminated Encephalomyelitis: Updates on An Inflammatory CNS Syndrome. Neurology, 87(9_Supplement_2):S38-S45.
Publisher | Google Scholor - Thompson, A. J., Banwell, B. L., Barkhof, F., Carroll, W. M., Coetzee, T., et al. (2018). Diagnosis of Multiple Sclerosis: 2017 Revisions of The McDonald Criteria. The Lancet Neurology, 17(2):162-173.
Publisher | Google Scholor - Dobson, R., Ramagopalan, S., Davis, A., Giovannoni, G. (2013). Cerebrospinal Fluid Oligoclonal Bands in Multiple Sclerosis and Clinically Isolated Syndromes: A Meta-Analysis of Prevalence, Prognosis and Effect of Latitude. Journal of Neurology, Neurosurgery & Psychiatry, 84(8):909-914.
Publisher | Google Scholor - Bot, J. C., Barkhof, F. (2009). Spinal-Cord MRI in Multiple Sclerosis: Conventional and Nonconventional MR Techniques. Neuroimaging Clinics of North America, 19(1):81-99.
Publisher | Google Scholor - Reindl, M., Waters, P. (2019). Myelin Oligodendrocyte Glycoprotein Antibodies in Neurological Disease. Nature Reviews Neurology, 15(2):89-102.
Publisher | Google Scholor - Freedman, M. S., Thompson, E. J., Deisenhammer, F., Giovannoni, G., Grimsley, G., et al. (2005). Recommended Standard of Cerebrospinal Fluid Analysis in The Diagnosis of Multiple Sclerosis: A Consensus Statement. Archives of Neurology, 62(6):865-870.
Publisher | Google Scholor - Schwarz, S., Mohr, A., Knauth, M., Wildemann, B., Storch-Hagenlocher, B. (2001). Acute Disseminated Encephalomyelitis: A Follow-Up Study of 40 Adult Patients. Neurology, 56(10):1313-1318.
Publisher | Google Scholor - Cortese, I., Chaudhry, V., So, Y. T., Cantor, F., Cornblath, D. R., et al. (2011). Evidence-Based Guideline Update: Plasmapheresis in Neurologic Disorders: Report of The Therapeutics and Technology Assessment Subcommittee of The American Academy of Neurology. Neurology, 76(3):294.
Publisher | Google Scholor - Schwartz, J., Winters, J. L., Padmanabhan, A., Balogun, R. A., Delaney, M., et al. (2013). Guidelines on The Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from The Writing Committee of The American Society for Apheresis: The Sixth Special Issue. Journal of Clinical Apheresis, 28(3):145-284.
Publisher | Google Scholor - Abboud, H., Petrak, A., Mealy, M., Sasidharan, S., Siddique, L., et al. (2016). Treatment of Acute Relapses in Neuromyelitis Optica: Steroids Alone Versus Steroids Plus Plasma Exchange. Multiple Sclerosis Journal, 22(2):185-192.
Publisher | Google Scholor - Kirshblum S, O’Connor KC. (2019). Spinal Cord Injury and Demyelinating Disease Rehabilitation Principles (Myelitis/NMOSD/MOGAD). 11(7).
Publisher | Google Scholor - Gardner, A., Gardner, E., Morley, T. (2011). Cauda Equina Syndrome: A Review of The Current Clinical and Medico-Legal Position. European Spine Journal, 20(5):690-697.
Publisher | Google Scholor - Dionne, N., Adefolarin, A., Kunzelman, D., Trehan, N., Finucane, L., et al. (2019). What is The Diagnostic Accuracy of Red Flags Related to Cauda Equina Syndrome (CES), When Compared to Magnetic Resonance Imaging (MRI)? A Systematic Review. Musculoskeletal Science and Practice, 42:125-133.
Publisher | Google Scholor - Leonhard, S. E., Mandarakas, M. R., Gondim, F. A., Bateman, K., Ferreira, M. L., et al. (2019). Diagnosis and Management of Guillain-Barré Syndrome in Ten Steps. Nature Reviews Neurology, 15(11):671-683.
Publisher | Google Scholor - Hughes, R. A., Cornblath, D. R. (2005). Guillain-Barre Syndrome. The Lancet, 366(9497):1653-1666.
Publisher | Google Scholor - Willison, H. J., Jacobs, B. C., van Doorn, P. A. (2016). Guillain-Barre Syndrome. The Lancet, 388(10045):717-727.
Publisher | Google Scholor - Houten, J. K., Noce, L. A. (2008). Clinical Correlations of Cervical Myelopathy and The Hoffmann Sign. Journal of Neurosurgery: Spine, 9(3):237-242.
Publisher | Google Scholor - Young, W. F. (2000). Cervical Spondylotic Myelopathy: A Common Cause of Spinal Cord Dysfunction in Older Persons. American Family Physician, 62(5):1064-1070.
Publisher | Google Scholor
